ICON Public Limited Company (ICLR)

USD 204.4

(0.56%)

Market Cap (In USD)

16.87 Billion

Revenue (In USD)

8.12 Billion

Net Income (In USD)

612.33 Million

Avg. Volume

633.98 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
183.38-347.72
PE
-
EPS
-
Beta Value
1.251
ISIN
IE0005711209
CUSIP
G4705A100
CIK
1060955
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Dr. Steven A. Cutler MBA, Ph.D.
Employee Count
-
Website
https://www.iconplc.com
Ipo Date
1998-05-15
Details
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.